129 related articles for article (PubMed ID: 34265455)
1. Antiobesity Medication Use Among Overweight and Obese Adults in the United States: 2015-2018.
MacEwan J; Kan H; Chiu K; Poon JL; Shinde S; Ahmad NN
Endocr Pract; 2021 Nov; 27(11):1139-1148. PubMed ID: 34265455
[TBL] [Abstract][Full Text] [Related]
2. Economic outcomes of antiobesity medication use among adults in the United States: A retrospective cohort study.
Watkins S; Toliver JC; Kim N; Whitmire S; Garvey WT
J Manag Care Spec Pharm; 2022 Oct; 28(10):1066-1079. PubMed ID: 35856489
[No Abstract] [Full Text] [Related]
3. Pharmacotherapy for the Treatment of Overweight and Obesity in Children, Adolescents, and Young Adults in a Large Health System in the US.
Czepiel KS; Perez NP; Campoverde Reyes KJ; Sabharwal S; Stanford FC
Front Endocrinol (Lausanne); 2020; 11():290. PubMed ID: 32477270
[TBL] [Abstract][Full Text] [Related]
4. Real-world primary nonadherence to antiobesity medications.
Kan H; Bae JP; Dunn JP; Buysman EK; Gronroos NN; Swindle JP; Bengtson LGS; Ahmad N
J Manag Care Spec Pharm; 2023 Oct; 29(10):1099-1108. PubMed ID: 37594848
[No Abstract] [Full Text] [Related]
5. Clinical, economic, and health-related quality of life outcomes in patients with overweight or obesity in the United States: 2016-2018.
MacEwan JP; Chiu K; Ahmad NN; Sacks N; Shinde S; Poon JL; Kan H
Obes Sci Pract; 2024 Feb; 10(1):e726. PubMed ID: 38263999
[TBL] [Abstract][Full Text] [Related]
6. Obesity is associated with significantly increased risk for diarrhoea after controlling for demographic, dietary and medical factors: a cross-sectional analysis of the 2009-2010 National Health and Nutrition Examination Survey.
Ballou S; Singh P; Rangan V; Iturrino J; Nee J; Lembo A
Aliment Pharmacol Ther; 2019 Nov; 50(9):1019-1024. PubMed ID: 31532005
[TBL] [Abstract][Full Text] [Related]
7. Use of medications associated with weight change among participants in the All of Us research programme.
Almazan E; Schwartz JL; Gudzune KA
Clin Obes; 2023 Oct; 13(5):e12609. PubMed ID: 37455380
[TBL] [Abstract][Full Text] [Related]
8. Association of patient characteristics and insurance type with anti-obesity medications prescribing and fills.
Gasoyan H; Pfoh ER; Schulte R; Sullivan E; Le P; Rothberg MB
Diabetes Obes Metab; 2024 May; 26(5):1687-1696. PubMed ID: 38287140
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Cost Benefits of Anti-Obesity Medication for US Veterans Participating in the MOVE! Weight Management Program.
Garvey WT; Cheng M; Ramasamy A; Smolarz BG; Park S; Kumar N; Kim N; DerSarkissian M; Bhak RH; Duh MS; Wu M; Hansen S; Young-Xu Y
Popul Health Manag; 2023 Feb; 26(1):72-82. PubMed ID: 36735596
[No Abstract] [Full Text] [Related]
10. Prescription medication use among normal weight, overweight, and obese adults, United States, 2005-2008.
Kit BK; Ogden CL; Flegal KM
Ann Epidemiol; 2012 Feb; 22(2):112-9. PubMed ID: 22100542
[TBL] [Abstract][Full Text] [Related]
11. The association between previous use of anti-obesity medication and semaglutide weight loss outcomes.
Ghusn W; Fansa S; Anazco D; Tama E; Cifuentes L; Gala K; De La Rosa A; Sacoto D; Campos A; Feris F; Hurtado D; Acosta A
Diabetes Obes Metab; 2024 Jun; 26(6):2167-2175. PubMed ID: 38469598
[TBL] [Abstract][Full Text] [Related]
12. The Societal Value of Broader Access to Antiobesity Medications.
Kabiri M; Sexton Ward A; Ramasamy A; van Eijndhoven E; Ganguly R; Smolarz BG; Zvenyach T; Goldman DP; Baumgardner JR
Obesity (Silver Spring); 2020 Feb; 28(2):429-436. PubMed ID: 31869002
[TBL] [Abstract][Full Text] [Related]
13. THE BENEFIT OF SHORT-TERM WEIGHT LOSS WITH ANTI-OBESITY MEDICATIONS IN REAL-WORLD CLINICAL PRACTICE.
Shibuya K; Ali KF; Ji X; Milinoivh A; Bauman J; Kattan MW; Pantalone KM; Burguera B
Endocr Pract; 2019 Oct; 25(10):1022-1028. PubMed ID: 31241358
[No Abstract] [Full Text] [Related]
14. Effect of the women's health initiative on prescription anti-osteoporosis medication utilization.
Farley JF; Blalock SJ; Cline RR
Osteoporos Int; 2008 Nov; 19(11):1603-12. PubMed ID: 18373048
[TBL] [Abstract][Full Text] [Related]
15. Weight loss experiences and willingness to intervention with pharmacotherapy among obese and very obese Danish people.
Jain P; Røstbjerg AS; Haase CL; Rhee NA
Phys Sportsmed; 2016 Sep; 44(3):201-7. PubMed ID: 27254773
[TBL] [Abstract][Full Text] [Related]
16. Pre-Pregnancy Weight Status Is Associated with Diet Quality and Nutritional Biomarkers during Pregnancy.
Shin D; Lee KW; Song WO
Nutrients; 2016 Mar; 8(3):162. PubMed ID: 26978398
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life and weight loss among overweight and obese U.S. adults, 2001 to 2002.
Bish CL; Michels Blanck H; Maynard LM; Serdula MK; Thompson NJ; Kettel Khan L
Obesity (Silver Spring); 2006 Nov; 14(11):2042-53. PubMed ID: 17135622
[TBL] [Abstract][Full Text] [Related]
18. Beverage intake among preschool children and its effect on weight status.
O'Connor TM; Yang SJ; Nicklas TA
Pediatrics; 2006 Oct; 118(4):e1010-8. PubMed ID: 17015497
[TBL] [Abstract][Full Text] [Related]
19. The Association Among Overweight, Obesity, and Low Back Pain in U.S. Adults: A Cross-Sectional Study of the 2015 National Health Interview Survey.
Peng T; Pérez A; Pettee Gabriel K
J Manipulative Physiol Ther; 2018 May; 41(4):294-303. PubMed ID: 29459122
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
